Precipio: Christina Valauri, Douglas Fisher
Precipio has appointed Christina Valauri to its board of directors effective Jan. 1. She brings a 30-year track record as a senior healthcare analyst and has held leadership roles that include US and global head of equity research and managing director at Cantor Fitzgerald, and senior equity research management roles at firms including ING, Credit Lyonnais (acquired by Credit Agricole), and Natixis. She has received the Award for Excellence in Medical Education Public Affairs from the Association of American Medical Colleges. Valauri is also the founding partner and CEO of Sagestone Advisory and currently serves as an entrepreneur in residence at Weill Cornell Medicine BioVenture eLab. She earned her BA in biology from Reed College and an MBA from Cornell University.
The company also announced that after serving on Precipio's board for 6 years, Douglas Fisher is stepping down but will remain as an observer moving forward.